he results, published in JAMA Neurology, indicate that early age at menopause may be a risk factor for AD dementia, but that women who were prescribed HT around the age of menopause onset did not show increased risk.
The study showed that the highest levels of tau, a protein involved in Alzheimer's, were only observed in hormone therapy users who reported a long delay between age at menopause onset and their initiation of the therapy
Women who have an early menopause may be at high risk of developing Alzheimer's disease, but those who were prescribed hormone therapy around the age of menopause onset did not show increased risk, finds a study.Premature menopause, defined as .